Unknown

Dataset Information

0

PD-1 Blockade Reverses Obesity-Mediated T Cell Priming Impairment.


ABSTRACT: Despite obesity reaching pandemic proportions, its impact on antigen-specific T cell responses is still unclear. We have recently demonstrated that obesity results in increased expression of PD-1 on T cells, and checkpoint blockade targeting PD-1/PD-L1 surprisingly resulted in greater clinical efficacy in cancer therapy. Adverse events associated with this therapy center around autoimmune reactions. In this study, we examined the impact of obesity on T cell priming and on autoimmune pathogenesis using the mouse model experimental autoimmune encephalomyelitis (EAE), which is mediated by autoreactive myelin-specific T cells generated after immunization. We observed that diet-induced obese (DIO) mice had a markedly delayed EAE onset and developed milder clinical symptoms compared to mice on control diet (CD). This delay was associated with impaired generation of myelin-specific T cell numbers and concurrently correlated with increased PD-L1 upregulation on antigen-presenting cells in secondary lymphoid organs. PD-1 blockade during the priming stage of EAE restored disease onset and severity and increased numbers of pathogenic CD4+ T cells in the central nervous system (CNS) of DIO mice to similar levels to those of CD mice. Administration of anti-PD-1 after onset of clinical symptoms did not increase EAE pathogenesis demonstrating that initial priming is the critical juncture affected by obesity. These findings demonstrate that obesity impairs antigen-specific T cell priming, but this can be reversed with PD-1 blockade. Our results further suggest that PD-1 blockade may increase the risk of autoimmune toxicities, particularly in obesity.

SUBMITTER: Le CT 

PROVIDER: S-EPMC7658608 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications


Despite obesity reaching pandemic proportions, its impact on antigen-specific T cell responses is still unclear. We have recently demonstrated that obesity results in increased expression of PD-1 on T cells, and checkpoint blockade targeting PD-1/PD-L1 surprisingly resulted in greater clinical efficacy in cancer therapy. Adverse events associated with this therapy center around autoimmune reactions. In this study, we examined the impact of obesity on T cell priming and on autoimmune pathogenesis  ...[more]

Similar Datasets

| S-EPMC5016238 | biostudies-literature
| S-EPMC8045409 | biostudies-literature
| S-EPMC9213603 | biostudies-literature
| S-EPMC9335501 | biostudies-literature
| S-EPMC8400712 | biostudies-literature
| S-EPMC6205194 | biostudies-literature
| S-EPMC5568784 | biostudies-literature
| S-EPMC5555220 | biostudies-literature
| S-EPMC9445877 | biostudies-literature
| S-EPMC6324991 | biostudies-literature